Badania pokazuj, e u czci pacjentw po zakoczeniu stosowania leku dochodzi do ponownego wzrostu masy ciaa, a take pogorszenia parametrw metabolicznych w tym stenia glukozy we krwi i wydzielania insuliny
Heres what the research says (and doesnt), what experts think might be going on, and how to support your body and your libido no matter where you are on your health journey
Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients
The plan is to follow the patients for 5 years and 5 weeks to target the first 1225 MACE [12]
Act 3: The Stacking Question What Longevity Experts Say About Combining Both The most sophisticated practitioners in the longevity space don't typically ask, "Should I use GLP-1 or BPC-157?" Instead, they ask, "When does each one belong in a protocol, and can they safely coexist?" The Complementary Logic Longevity-focused physicians and sports medicine practitioners have begun articulating a clear rationale for combining these compounds in specific patient profiles: The GLP-1 Layer: Addresses the metabolic side (reducing fat, improving insulin, lowering cardiovascular risk)
